Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234733 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 5 Pages |
Abstract
SBRT for adrenal metastases is well tolerated. Most patients developed widespread metastases shortly after treatment. Local control was poor, although this was a patient population selected for adverse risk factors, such as bulky disease. Additional studies are needed to determine the efficacy of SBRT for oligometastatic adrenal metastases, given the propensity of these patients to develop further disease progression.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sheema M.D., Yuhchyau Ph.D., M.D., Alan W. M.D., M.P.H., Ann G. B.S., Abraham C.M.D., Paul M.D., Michael T. M.D., Ph.D.,